Related Experiment Video
Updated: May 7, 2026

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
Published on: November 18, 2022
Celastrol prevents cadmium-induced neuronal cell death via targeting JNK and PTEN-Akt/mTOR network
Sujuan Chen1, Chenjian Gu1, Chong Xu1
1Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
Abstract:
Cadmium (Cd), a toxic environmental contaminant, induces neurodegenerative diseases. Celastrol, a plant-derived triterpene, has shown neuroprotective effects in various disease models. However, little is known regarding the effect of celastrol on Cd-induced neurotoxicity. Here, we show that celastrol protected against Cd-induced apoptotic cell death in neuronal cells. This is supported by the findings that celastrol strikingly attenuated Cd-induced viability reduction, morphological change, nuclear fragmentation, and condensation, as well as activation of caspase-3 in neuronal cells. Concurrently, celastrol remarkably blocked Cd-induced phosphorylation of c-Jun N-terminal kinase (JNK), but not extracellular signal-regulated kinases 1/2 and p38, in neuronal cells. Inhibition of JNK by SP600125 or over-expression of dominant negative c-Jun potentiated celastrol protection against Cd-induced cell death. Furthermore, pre-treatment with celastrol prevented Cd down-regulation of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and activation of phosphoinositide 3'-kinase/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling in neuronal cells. Over-expression of wild-type PTEN enhanced celastrol inhibition of Cd-activated Akt/mTOR signaling and cell death in neuronal cells. The findings indicate that celastrol prevents Cd-induced neuronal cell death via targeting JNK and PTEN-Akt/mTOR network. Our results strongly suggest that celastrol may be exploited for the prevention of Cd-induced neurodegenerative disorders. Celastrol, a plant-derived triterpene, has shown neuroprotective effects. However, little is known regarding the effect of celastrol on cadmium (Cd) neurotoxicity. This study underscores that celastrol prevents Cd-induced neuronal apoptosis via inhibiting activation of JNK (c-Jun N-terminal kinase) and Akt/mTOR network. Celastrol suppresses Cd-activated Akt/mTOR pathway by elevating PTEN (phosphatase and tensin homolog). The findings suggest that celastrol may be exploited for the prevention of Cd-induced neurodegenerative disorders.
Insights
Celastrol, a plant compound, protects neurons from cadmium toxicity by inhibiting JNK and activating the PTEN-Akt/mTOR pathway. This suggests celastrol could prevent neurodegenerative disorders caused by cadmium exposure.
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- Cadmium (Cd) is a toxic environmental contaminant linked to neurodegenerative diseases.
- Celastrol, a plant-derived triterpene, exhibits neuroprotective properties.
- The specific effects of celastrol on cadmium-induced neurotoxicity remain largely unexplored.
Purpose of the Study:
- To investigate the protective effects of celastrol against cadmium-induced neurotoxicity in neuronal cells.
- To elucidate the molecular mechanisms underlying celastrol's neuroprotective action in the context of cadmium exposure.
- To assess the potential of celastrol as a therapeutic agent for cadmium-induced neurodegenerative disorders.
Main Methods:
- Neuronal cell cultures were exposed to cadmium, with or without celastrol pre-treatment.
- Cell viability, apoptosis markers (caspase-3 activation, nuclear fragmentation), and signaling pathways (JNK, PTEN, Akt, mTOR) were assessed.
- Specific inhibitors (SP600125) and genetic manipulations (dominant-negative c-Jun, wild-type PTEN) were employed to dissect signaling pathways.
Main Results:
- Celastrol significantly attenuated cadmium-induced neuronal cell death, reducing apoptosis and morphological damage.
- Celastrol inhibited cadmium-induced c-Jun N-terminal kinase (JNK) phosphorylation.
- Celastrol prevented cadmium-induced down-regulation of PTEN and subsequent activation of the Akt/mTOR pathway.
Conclusions:
- Celastrol confers neuroprotection against cadmium toxicity by inhibiting JNK activation and modulating the PTEN-Akt/mTOR signaling network.
- Celastrol's mechanism involves up-regulating PTEN, which suppresses the pro-survival Akt/mTOR pathway.
- These findings highlight celastrol as a promising candidate for preventing cadmium-induced neurodegenerative diseases.
Related Concept Videos
Inhibition of Cdk Activity
MAPK Signaling Cascades
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
